Pfizer Recalls BP Drugs Because of Potential Carcinogen

The voluntary nationwide recall of the antihypertensive Accuretic and two generics was prompted by unacceptable levels of N-nitroso-quinapril, a likely carcinogen, in 11 lots.
News Alerts